What is the Paradigm Biopharmaceuticals (ASX: PAR) share price?
The PAR share price is $0.17, down 5.56% for the day, based on the latest available ASX market data.
What is Paradigm Biopharmaceuticals's market capitalisation?
Paradigm Biopharmaceuticals has a market capitalisation of $73.7M, making it the 916th-largest security listed on the ASX.
Does Paradigm Biopharmaceuticals pay a dividend?
PAR does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Paradigm Biopharmaceuticals profitable?
In its most recent reported period (ending 31 Dec 2025), PAR reported revenue of $25,150 and a net loss of $23.2M.
How many PAR shares are on issue?
Paradigm Biopharmaceuticals has approximately 433,387,382 shares on issue, based on its market capitalisation of $73.7M and current share price.
What sector is Paradigm Biopharmaceuticals in?
Paradigm Biopharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Paradigm Biopharmaceuticals list on the ASX?
Paradigm Biopharmaceuticals listed on the Australian Securities Exchange on 19 Aug 2015.
